AbbeyMoor Medical Inc. announced that it has received PMA approval from the US FDA for design changes to the Spanner Prostatic Stent.
These changes are aimed at further improving patient comfort over the current highly accepted levels, said Darren Cook, director of marketing with the company. Our goal is to hear an even greater percentage of our patient’s state that they are not aware of the device’s presence. According to Mark Whalen, VP of product development with the company, The approved changes to the device result in a significant increase in flexibility over the current Spanner design with no impact to the ease of delivery and removal of the device.
The Spanner Prostatic Stent is a temporary prostatic stent designed to assist men who are experiencing difficulty in urination due to prostatic obstruction. Device can be placed in physician with out the requirement of cystoscopy or anesthesia. It provides an alternative to intermittent catheterization, indwelling catheterization, or the use of a suprapubic tube in some patients.